Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Shanghai Stock Exchange 603168.SS

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Revenue for the year ending December 31, 2023: USD 90.84 M

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Revenue is USD 90.84 M for the year ending December 31, 2023, a 14.08% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Revenue for the year ending December 31, 2022 was USD 79.63 M, a -19.65% change year over year.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Revenue for the year ending December 31, 2021 was USD 99.11 M, a 80.59% change year over year.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Revenue for the year ending December 31, 2020 was USD 54.88 M, a -25.93% change year over year.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Revenue for the year ending December 31, 2019 was USD 74.09 M, a -16.11% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shanghai Stock Exchange: 603168.SS

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

CEO	Mr. Mingxiong Huang
IPO Date	July 2, 2014
Location	China
Headquarters	No. 1588 Xinming Road
Employees	1,385
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, auxiliary, cardiovascular, detoxification, diuretic row stone, gynecology, and infusion categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.

Key trends

Past 5 years